[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Liver Cirrhosis Market 2024 by Company, Regions, Type and Application, Forecast to 2030

May 2024 | 112 pages | ID: G790DAAD099AEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Liver Cirrhosis market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcohol abuse.

Alcohol has been identified as the strongest risk factor for liver cirrhosis.

The Global Info Research report includes an overview of the development of the Liver Cirrhosis industry chain, the market status of Hospitals (Alcoholic Cirrhosis, Atrophic Cirrhosis), Specialty Clinics (Alcoholic Cirrhosis, Atrophic Cirrhosis), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Liver Cirrhosis.

Regionally, the report analyzes the Liver Cirrhosis markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Liver Cirrhosis market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Liver Cirrhosis market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Liver Cirrhosis industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Alcoholic Cirrhosis, Atrophic Cirrhosis).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Liver Cirrhosis market.

Regional Analysis: The report involves examining the Liver Cirrhosis market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Liver Cirrhosis market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Liver Cirrhosis:

Company Analysis: Report covers individual Liver Cirrhosis players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Liver Cirrhosis This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Specialty Clinics).

Technology Analysis: Report covers specific technologies relevant to Liver Cirrhosis. It assesses the current state, advancements, and potential future developments in Liver Cirrhosis areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Liver Cirrhosis market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Liver Cirrhosis market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
  • Alcoholic Cirrhosis
  • Atrophic Cirrhosis
  • Biliary Cirrhosis
  • Cardiac Cirrhosis
  • Cryptogenic Cirrhosis
Market segment by Application
  • Hospitals
  • Specialty Clinics
Market segment by players, this report covers
  • F Hoffman La-Roche
  • GlaxoSmithKline
  • Gilead Sciences
  • Johnson & Johnson
  • Merck
  • Bristol-Myers Squibb
  • Conatus Pharmaceuticals
  • Gwo Xi Stem Cell Applied Technology
  • Instituto Grifols
  • Intercept Pharmaceuticals
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Liver Cirrhosis product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Liver Cirrhosis, with revenue, gross margin and global market share of Liver Cirrhosis from 2019 to 2024.

Chapter 3, the Liver Cirrhosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Liver Cirrhosis market forecast, by regions, type and application, with consumption value, from 2025 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Liver Cirrhosis.

Chapter 13, to describe Liver Cirrhosis research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Liver Cirrhosis
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Liver Cirrhosis by Type
  1.3.1 Overview: Global Liver Cirrhosis Market Size by Type: 2019 Versus 2023 Versus 2030
  1.3.2 Global Liver Cirrhosis Consumption Value Market Share by Type in 2023
  1.3.3 Alcoholic Cirrhosis
  1.3.4 Atrophic Cirrhosis
  1.3.5 Biliary Cirrhosis
  1.3.6 Cardiac Cirrhosis
  1.3.7 Cryptogenic Cirrhosis
1.4 Global Liver Cirrhosis Market by Application
  1.4.1 Overview: Global Liver Cirrhosis Market Size by Application: 2019 Versus 2023 Versus 2030
  1.4.2 Hospitals
  1.4.3 Specialty Clinics
1.5 Global Liver Cirrhosis Market Size & Forecast
1.6 Global Liver Cirrhosis Market Size and Forecast by Region
  1.6.1 Global Liver Cirrhosis Market Size by Region: 2019 VS 2023 VS 2030
  1.6.2 Global Liver Cirrhosis Market Size by Region, (2019-2030)
  1.6.3 North America Liver Cirrhosis Market Size and Prospect (2019-2030)
  1.6.4 Europe Liver Cirrhosis Market Size and Prospect (2019-2030)
  1.6.5 Asia-Pacific Liver Cirrhosis Market Size and Prospect (2019-2030)
  1.6.6 South America Liver Cirrhosis Market Size and Prospect (2019-2030)
  1.6.7 Middle East and Africa Liver Cirrhosis Market Size and Prospect (2019-2030)

2 COMPANY PROFILES

2.1 F Hoffman La-Roche
  2.1.1 F Hoffman La-Roche Details
  2.1.2 F Hoffman La-Roche Major Business
  2.1.3 F Hoffman La-Roche Liver Cirrhosis Product and Solutions
  2.1.4 F Hoffman La-Roche Liver Cirrhosis Revenue, Gross Margin and Market Share (2019-2024)
  2.1.5 F Hoffman La-Roche Recent Developments and Future Plans
2.2 GlaxoSmithKline
  2.2.1 GlaxoSmithKline Details
  2.2.2 GlaxoSmithKline Major Business
  2.2.3 GlaxoSmithKline Liver Cirrhosis Product and Solutions
  2.2.4 GlaxoSmithKline Liver Cirrhosis Revenue, Gross Margin and Market Share (2019-2024)
  2.2.5 GlaxoSmithKline Recent Developments and Future Plans
2.3 Gilead Sciences
  2.3.1 Gilead Sciences Details
  2.3.2 Gilead Sciences Major Business
  2.3.3 Gilead Sciences Liver Cirrhosis Product and Solutions
  2.3.4 Gilead Sciences Liver Cirrhosis Revenue, Gross Margin and Market Share (2019-2024)
  2.3.5 Gilead Sciences Recent Developments and Future Plans
2.4 Johnson & Johnson
  2.4.1 Johnson & Johnson Details
  2.4.2 Johnson & Johnson Major Business
  2.4.3 Johnson & Johnson Liver Cirrhosis Product and Solutions
  2.4.4 Johnson & Johnson Liver Cirrhosis Revenue, Gross Margin and Market Share (2019-2024)
  2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Merck
  2.5.1 Merck Details
  2.5.2 Merck Major Business
  2.5.3 Merck Liver Cirrhosis Product and Solutions
  2.5.4 Merck Liver Cirrhosis Revenue, Gross Margin and Market Share (2019-2024)
  2.5.5 Merck Recent Developments and Future Plans
2.6 Bristol-Myers Squibb
  2.6.1 Bristol-Myers Squibb Details
  2.6.2 Bristol-Myers Squibb Major Business
  2.6.3 Bristol-Myers Squibb Liver Cirrhosis Product and Solutions
  2.6.4 Bristol-Myers Squibb Liver Cirrhosis Revenue, Gross Margin and Market Share (2019-2024)
  2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.7 Conatus Pharmaceuticals
  2.7.1 Conatus Pharmaceuticals Details
  2.7.2 Conatus Pharmaceuticals Major Business
  2.7.3 Conatus Pharmaceuticals Liver Cirrhosis Product and Solutions
  2.7.4 Conatus Pharmaceuticals Liver Cirrhosis Revenue, Gross Margin and Market Share (2019-2024)
  2.7.5 Conatus Pharmaceuticals Recent Developments and Future Plans
2.8 Gwo Xi Stem Cell Applied Technology
  2.8.1 Gwo Xi Stem Cell Applied Technology Details
  2.8.2 Gwo Xi Stem Cell Applied Technology Major Business
  2.8.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Product and Solutions
  2.8.4 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Revenue, Gross Margin and Market Share (2019-2024)
  2.8.5 Gwo Xi Stem Cell Applied Technology Recent Developments and Future Plans
2.9 Instituto Grifols
  2.9.1 Instituto Grifols Details
  2.9.2 Instituto Grifols Major Business
  2.9.3 Instituto Grifols Liver Cirrhosis Product and Solutions
  2.9.4 Instituto Grifols Liver Cirrhosis Revenue, Gross Margin and Market Share (2019-2024)
  2.9.5 Instituto Grifols Recent Developments and Future Plans
2.10 Intercept Pharmaceuticals
  2.10.1 Intercept Pharmaceuticals Details
  2.10.2 Intercept Pharmaceuticals Major Business
  2.10.3 Intercept Pharmaceuticals Liver Cirrhosis Product and Solutions
  2.10.4 Intercept Pharmaceuticals Liver Cirrhosis Revenue, Gross Margin and Market Share (2019-2024)
  2.10.5 Intercept Pharmaceuticals Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Liver Cirrhosis Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
  3.2.1 Market Share of Liver Cirrhosis by Company Revenue
  3.2.2 Top 3 Liver Cirrhosis Players Market Share in 2023
  3.2.3 Top 6 Liver Cirrhosis Players Market Share in 2023
3.3 Liver Cirrhosis Market: Overall Company Footprint Analysis
  3.3.1 Liver Cirrhosis Market: Region Footprint
  3.3.2 Liver Cirrhosis Market: Company Product Type Footprint
  3.3.3 Liver Cirrhosis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Liver Cirrhosis Consumption Value and Market Share by Type (2019-2024)
4.2 Global Liver Cirrhosis Market Forecast by Type (2025-2030)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Liver Cirrhosis Consumption Value Market Share by Application (2019-2024)
5.2 Global Liver Cirrhosis Market Forecast by Application (2025-2030)

6 NORTH AMERICA

6.1 North America Liver Cirrhosis Consumption Value by Type (2019-2030)
6.2 North America Liver Cirrhosis Consumption Value by Application (2019-2030)
6.3 North America Liver Cirrhosis Market Size by Country
  6.3.1 North America Liver Cirrhosis Consumption Value by Country (2019-2030)
  6.3.2 United States Liver Cirrhosis Market Size and Forecast (2019-2030)
  6.3.3 Canada Liver Cirrhosis Market Size and Forecast (2019-2030)
  6.3.4 Mexico Liver Cirrhosis Market Size and Forecast (2019-2030)

7 EUROPE

7.1 Europe Liver Cirrhosis Consumption Value by Type (2019-2030)
7.2 Europe Liver Cirrhosis Consumption Value by Application (2019-2030)
7.3 Europe Liver Cirrhosis Market Size by Country
  7.3.1 Europe Liver Cirrhosis Consumption Value by Country (2019-2030)
  7.3.2 Germany Liver Cirrhosis Market Size and Forecast (2019-2030)
  7.3.3 France Liver Cirrhosis Market Size and Forecast (2019-2030)
  7.3.4 United Kingdom Liver Cirrhosis Market Size and Forecast (2019-2030)
  7.3.5 Russia Liver Cirrhosis Market Size and Forecast (2019-2030)
  7.3.6 Italy Liver Cirrhosis Market Size and Forecast (2019-2030)

8 ASIA-PACIFIC

8.1 Asia-Pacific Liver Cirrhosis Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Liver Cirrhosis Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Liver Cirrhosis Market Size by Region
  8.3.1 Asia-Pacific Liver Cirrhosis Consumption Value by Region (2019-2030)
  8.3.2 China Liver Cirrhosis Market Size and Forecast (2019-2030)
  8.3.3 Japan Liver Cirrhosis Market Size and Forecast (2019-2030)
  8.3.4 South Korea Liver Cirrhosis Market Size and Forecast (2019-2030)
  8.3.5 India Liver Cirrhosis Market Size and Forecast (2019-2030)
  8.3.6 Southeast Asia Liver Cirrhosis Market Size and Forecast (2019-2030)
  8.3.7 Australia Liver Cirrhosis Market Size and Forecast (2019-2030)

9 SOUTH AMERICA

9.1 South America Liver Cirrhosis Consumption Value by Type (2019-2030)
9.2 South America Liver Cirrhosis Consumption Value by Application (2019-2030)
9.3 South America Liver Cirrhosis Market Size by Country
  9.3.1 South America Liver Cirrhosis Consumption Value by Country (2019-2030)
  9.3.2 Brazil Liver Cirrhosis Market Size and Forecast (2019-2030)
  9.3.3 Argentina Liver Cirrhosis Market Size and Forecast (2019-2030)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Liver Cirrhosis Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Liver Cirrhosis Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Liver Cirrhosis Market Size by Country
  10.3.1 Middle East & Africa Liver Cirrhosis Consumption Value by Country (2019-2030)
  10.3.2 Turkey Liver Cirrhosis Market Size and Forecast (2019-2030)
  10.3.3 Saudi Arabia Liver Cirrhosis Market Size and Forecast (2019-2030)
  10.3.4 UAE Liver Cirrhosis Market Size and Forecast (2019-2030)

11 MARKET DYNAMICS

11.1 Liver Cirrhosis Market Drivers
11.2 Liver Cirrhosis Market Restraints
11.3 Liver Cirrhosis Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Liver Cirrhosis Industry Chain
12.2 Liver Cirrhosis Upstream Analysis
12.3 Liver Cirrhosis Midstream Analysis
12.4 Liver Cirrhosis Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer


More Publications